Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes
Anticoagulants are a potential treatment for the thrombotic complications resulting from COVID-19. We aimed to determine the association between anticoagulant use and adverse outcomes among hospitalized patients with COVID-19. We used data from the COVID-19 International Collaborative Research Proje...
Main Authors: | Ya-Hui Yu, In-Sun Oh, Han Eol Jeong, Robert W. Platt, Antonios Douros, Ju-Young Shin, Kristian B. Filion |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1034636/full |
Similar Items
-
Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses
by: Han Eol Jeong, et al.
Published: (2023-02-01) -
Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
by: Camille Simard, et al.
Published: (2022-08-01) -
Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort study
by: Dongwon Yoon, et al.
Published: (2023-11-01) -
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials.
by: Jihoon Lim, et al.
Published: (2022-01-01) -
Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi‐database cohort study
by: Antonios Douros, et al.
Published: (2022-01-01)